ArticlePDF Available

Acupuncture is associated with a positive effect on odour discrimination in patients with postinfectious smell loss—a controlled prospective study

Authors:

Abstract and Figures

Introduction Smell disorders are common in the general population and occur e.g., after infections, trauma or idiopathically Treatment strategies for smell loss range from surgery, medication to olfactory training, depending on the pathology, but they are limited This study examined the effect of acupuncture on olfactory function. Methods Sixty patients with smell loss following infections of the upper respiratory tract were included in this investigation Half of the study group were randomly assigned to verum acupuncture and the other half to sham acupuncture Olfaction was measured by means of the “Sniffin’ Sticks” test battery (odour threshold, discrimination and identification). Results Compared to sham acupuncture, verum was associated with an improvement of smell function as measured by the TDI score ( p = 0.039) The improvement was largely determined by improvement in odour discrimination, and was significantly better in patients with a shorter duration of the disorder. Conclusion The present results suggest that acupuncture is an effective supplementary treatment option for patients with olfactory loss.
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
1 3
European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
https://doi.org/10.1007/s00405-021-06872-9
RHINOLOGY
Acupuncture isassociated withapositive effect onodour
discrimination inpatients withpostinfectious smell loss—a controlled
prospective study
TanjaDrews1,2 · ThomasHummel1· BettinaRochlitzer1,3· BettinaHauswald1· AntjeHähner1
Received: 5 February 2021 / Accepted: 4 May 2021 / Published online: 25 May 2021
© The Author(s) 2021
Abstract
Introduction Smell disorders are common in the general population and occur e.g., after infections, trauma or idiopathically
Treatment strategies for smell loss range from surgery, medication to olfactory training, depending on the pathology, but
they are limited This study examined the effect of acupuncture on olfactory function.
Methods Sixty patients with smell loss following infections of the upper respiratory tract were included in this investigation
Half of the study group were randomly assigned to verum acupuncture and the other half to sham acupuncture Olfaction was
measured by means of the “Sniffin’ Sticks” test battery (odour threshold, discrimination and identification).
Results Compared to sham acupuncture, verum was associated with an improvement of smell function as measured by the
TDI score (p = 0.039) The improvement was largely determined by improvement in odour discrimination, and was signifi-
cantly better in patients with a shorter duration of the disorder.
Conclusion The present results suggest that acupuncture is an effective supplementary treatment option for patients with
olfactory loss.
Keywords Acupuncture· Smell loss· Olfaction· Sniffin’ sticks
Introduction
Olfactory impairment is common in the general population
and results in a loss of quality of life [1, 2]. While there
are several valid and reliable tools available for the diagno-
sis of olfactory loss, the treatment possibilities of olfactory
dysfunction are limited Causes of smell disorders include
sinunasal diseases, acute infections of the upper respiratory
tract, head trauma, neurodegenerative diseases, medication
including chemotherapy, environmental factors and ageing
[35]. In effect, approximately 5% of the population are
estimated to exhibit functional anosmia with the prevalence
being highest in the older population [6, 7].
Treatment strategies for smell loss are related to the cause
of the disorder Particularly effective therapies are available
for chronic inflammation of the upper airway system includ-
ing surgery or topical or systemic anti-inflammatory medica-
tion [8, 9]. Interestingly, in clinical routine topical steroids
are used irrespective of the aetiology [10]. Another effective
method in treating various forms of smell loss is olfactory
training [11]. Systematic, repeated exposure to odours may
lead to an improvement of olfactory function in patients
with post-infectious, posttraumatic and neurodegenerative
smell loss [1115]. Nevertheless, apart from these treatment
options, therapies for olfactory loss are relatively poorly
developed [16, 17].
Hence, the present study focuses on the treatment of
patients with postinfectious smell loss who represent one of
the largest groups of patients with olfactory disorders with
about 18–45% of patients presenting themselves with smell
loss [1]. Postinfectious smell loss is caused by an infection
of the upper respiratory tract (URTI) that persists after the
* Tanja Drews
Tanja.Drews@uniklinikum-dresden.de
1 Department ofOtorhinolaryngology, Smell andTaste
Clinic, Technische Universität Dresden, Technical
University ofDresden Medical School, Fetscherstrasse 74,
01307Dresden, Germany
2 Department ofOtorhinolaryngology,
Bundeswehrkrankenhaus Berlin, Scharnhorststr 13,
10115Berlin, Germany
3 Klinik Für Augenheilkunde, Städtisches Klinikum Görlitz,
Girbigsdorfer Str 1-3, Görlitz, Germany
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1330 European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
1 3
infection has passed [18]. The exact pathological mechanism
is unclear but its possible lesion sites include damage to
the sustentacular cells or the olfactory receptor neurons in
the mucosa or the olfactory bulb [19, 20]. URTI-associated
smell loss typically occurs after the fifth decade of life and
is seen more frequently in women than in men [18]. About
25% of these patients describe parosmia, possibly due to the
partial loss of olfactory receptors [21]. In addition to olfac-
tory training, treatment strategies include vitamin A nasal
drops or systemic alpha-lipoic acid [22, 23].
Sporadically, acupuncture has been used in postinfectious
olfactory loss [24]. Acupuncture is an important part of tra-
ditional Chinese medicine Those that use needle acupunc-
ture believe that every living being is filled with the energy
“Qi” that flows within the body along meridians on which
the individual acupuncture points are located Diseases are
explained by disruptions in the flow of Qi [25, 26].
The needling of acupuncture points has been shown to be
associated with analgesic and relaxing effects It is, therefore,
not only positive for the body but similarly for the men-
tal state of the patient Needling stimulates nerves, which
results in an activation of the central nervous system [27].
The procedure involves the application of 10–20 needles
to certain cutaneous points, where they remain for about
30min [28]. The points are determined by palpation The
procedure is repeated on different days There should be a
noticeable effect, for example in the form of improvement
of symptoms, after about 8 sessions on different days [29].
Side effects are rare, with only about 3% of treated patients
describing pain, local infections and hematoma [28].
So far there are only a few studies, that will now be
described, that have examined the effect of acupuncture
on smell disorders in a controlled way However, previous
results already indicate a positive effect of this approach
In the study by Vent etal., 15 patients with postinfectious
smell loss were treated with acupuncture and compared
to 15 patients who had been treated with Vitamin B After
10weeks of acupuncture treatment, there was a significant
improvement in smell function in the acupuncture group
compared to the Vitamin B group [30]. However, the signifi-
cance of this study was questioned later [31]. A non-blinded
control condition was used in a study by Dai etal who
reported olfactory improvement in postinfectious patients
after acupuncture compared to a patient group without treat-
ment [32]. Hauswald etal applied acupuncture in the context
of a non-randomized, non-controlled study in a larger group
of patients with various aetiologies of smell loss [33]. They
reported a significant improvement in olfactory function,
especially in postinfectious smell loss Anzinger used laser
acupuncture on healthy subjects in a double-blinded single-
application approach and found a positive, acute effect on
olfaction which was measured using the Sniffin’ Sticks Test
[34]. Furthermore, in a case report smell improvement in
one patient receiving acupuncture treatment was reported,
this was based, however, on self-assessment [35].
The aim of this single-centre, prospective, placebo-con-
trolled, patient-blinded study was to investigate the change
of olfactory function in patients with postinfectious smell
loss following 12 acupuncture sessions, twice per week,
each 30min long Based on previous reports, we expected
that acupuncture has a positive effect on smell function in
postinfectious patients.
Methods
Patients
Sixty subjects were recruited consecutively between August
2012 and February 2013 at the Smell and Taste Clinic of
the Department of Otorhinolaryngology of the TU Dres-
den All patients had received the diagnosis of postinfec-
tious smell loss following a detailed, structured history and
a full otorhinolaryngological examination including nasal
endoscopy [36]. Inclusion and exclusion criteria are listed in
Table1 All participants provided written informed consent
The study was approved by the Ethics Committee of the
Medical Faculty of the TU Dresden (ethics approval number
EK 78,032,012).
Olfactory testing
The “Sniffin’ Sticks” test battery was applied before and
after treatment involving tests for odour threshold, odour
discrimination and odour identification [37]. The sum of
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Smell loss directly following an URTI Symptom-free interval
18years of age or older URTI during the study period
Written informed consent Neurological diseases that may impair the sense of smell (e.g Parkinson’s or
Alzheimer’s disease)
Absence of chronic infection of the nasal cavities or sinuses Dermatological problems that may complicate the application of the needles
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1331European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
1 3
the scores from the three subtests resulted in the TDI-score
(Threshold, Discrimination and Identification).
Acupuncture treatment
Subjects were randomly attributed to treatments so that one
half received verum acupuncture and the other half received
sham acupuncture, sham meaning that fake points, rather
than actual acupuncture points were needled Both groups
underwent acupuncture 12 times with approximately 2 ses-
sions per week The acupuncture as well as the sham acu-
puncture consisted of needling specific points using sterile
acupuncture needles This was performed by the same person
in every session, and in every session the same points were
needled.
After completion of the study treatment, patients who
had received the placebo condition were offered the verum
acupuncture following the conclusion of the study.
The points chosen for the verum acupuncture were com-
parable to those used in previous studies and can be seen
in Image 1 [30, 33]. All points were used symmetrically on
both sides of the body.
The points used in the sham acupuncture were the same
points used in the ACUSAR- study [38]. The points used are
listed in Table2.
Statistical analysis
The data were analysed using SPSS 27.0 (SPSS Inc., Chi-
cago, Ill, USA) If not mentioned otherwise, all data are
shown as means ± standard deviation (SD) or numbers (%),
significance level was set at p < 0.05 (two-tailed test) Pear-
son statistics were used for correlational analyses.
Results
Sixty patients, 23 males and 37 females were included in
the study The verum group was comprised of 17 hypos-
mic patients and 13 functionally anosmic patients, the sham
acupuncture group of 2 normosmic, 14 hyposmic and 14
anosmic patients All patients completed the study without
any exception.
No adverse effects were encountered during the acupunc-
ture sessions Descriptive statistics of the patient groups at
baseline are shown in Table3.
When comparing the change of TDI scores before and
after treatment the verum group performed better than the
sham acupuncture group (F = 4.45, p = 0.04) Concern-
ing individual subtests, only odour discrimination was
significantly different between the two groups (F = 9.48,
p = 0.003), but not odour threshold (F = 2.61, p = 0.11) and
odour identification (F = 0.93, p = 0.34) These results can
Image 1 Verum-points on face and ear (Bl 3, LG23, Di 20, NP 12,
Op 16), on the arm (Di 4, Lu 7) and on the leg (MP 6, Ma 44)
Table 2 Verum and placebo acupuncture points
Location Acupuncture Points Points for
sham acu-
puncture
Head Bladder 3 /
Governing Vessel 23 /
Large intestine 20 /
Extra point 12 /
Ear Ear 16 /
Arm Lung 7 Deltoideus
Large intestine 4 Upper Arm
Leg Spleen 6 Thigh 1
Stomach 44 Thigh 2
Back / Back 1
/ Back 2
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1332 European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
1 3
be seen in Fig 1 With regard to a clinically significant
improvement on an individual level, 6 of 30 subjects from
the verum group (20%) exhibited improvement of more
than 5.5 points in the TDI score, whereas only 3 of 30 sub-
jects exhibited improvement in the placebo group (10%)
[39]. While this is not a statistically significant result, it
does deserve mention.
When analysing data across both groups there was a
significant correlation between the change of TDI scores
and the duration of the disease (r = − 0.4, p = 0.001) wit h
Table 3 descriptive statistics
at baseline before treatment;
TDI: summated score from
odour threshold, discrimination,
and identification; standard
deviation in brackets
Verum acupuncture Sham acupuncture p-value
Age in years 63.0 (13.6) 66.3 (10.1) 0.29
duration of smell loss in years 3.9 (4.3) 5.1 (5.3) 0.34
TDI score 17.12 (5.62) 17.47 (6.99) 0.86
Odour Threshold 2.08 (1.68) 2.29 (1.79) 0.84
Odour Discrimination 8.37 (2.53) 8.03 (2.99) 0.75
Odour Identification 6.67 (2.83) 7.13 (3.57) 0.60
Fig 1 Mean differences (scores
after treatment minus scores
before acupuncture) of olfac-
tory test results with Standard
Errors; * shows significant
results
Fig 2 Correlation between
changes in TDI scores and dura-
tion of smell loss
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1333European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
1 3
better outcome in patients with a shorter duration of the
olfactory loss (Fig 2).
Discussion
The present results indicated that acupuncture has a posi-
tive effect on olfactory function in patients with postin-
fectious smell loss We found a significant improvement in
general olfactory performance as well as an improvement
in odour discrimination in verum acupuncture compared
to sham treatment On an individual level, verum acupunc-
ture increased olfactory function in 20% of the subjects
compared to 10% of subjects who had sham acupuncture
Further, the treatment response correlated negatively with
the duration of smell loss—the longer the smell loss the
less likely it was to achieve a positive treatment response
A similar relation between the duration of olfactory loss
and improvement of olfactory function has been reported
several times [15, 40]. Acupuncture appeared to be useful
independently from the patients´ age.
The results of our study confirm some of the findings
of previous studies. The present research tried to avoid
several issues that limited the significance of previous
studies, e.g., lack of a control group, heterogeneous
patient groups, or low case numbers [30, 3234]. We,
therefore, included a homogenous, thoroughly diag-
nosed patient group with postinfectious smell loss, and
a patient-blinded control condition to minimize possi-
ble bias. The therapy was well accepted by the patients,
which can be seen from the lack of dropouts and the
absence of side effects.
It is interesting to note that odour discrimination, but
not odour threshold, improved in response to acupunc-
ture An explanation could be that odour discrimination
appears to involve higher-level cognitive functions to a
higher degree compared to odour thresholds [41]. Acu-
puncture has previously been shown to have effects on
cognitive function tested with the Mini-Mental State
Examination Test in patients following a stroke [42, 43].
Therefore, it might be hypothesized that acupuncture has
positive effects on the cognitive processing of odours
For example, the outcome of the test might have been
positively modified by different levels of attention and
concentration.
Acupuncture is an important part of traditional Chi-
nese medicine When analysing this form of treatment,
it is important to remember that the classical scientific
proof is difficult to obtain when the foundation of the treat-
ment includes something that evades measurement It is,
however, possible to focus on the effects of the treatment,
which is what was done in this study.
Conclusion
The present results suggest that acupuncture is helpful in
patients with postinfectious olfactory loss. The shorter
the time span between smell loss and treatment, the more
likely it is for the treatment to have a positive effect.
With hardly any negative side effects being described,
acupuncture should be considered as a supplementary
treatment.
Future studies need to determine whether the observed
increase of olfactory sensitivity is temporary or is lasting
for a longer period of time.
Funding Open Access funding enabled and organized by Projekt
DEAL.
Declarations
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval The study was carried out in accordance with the
Code of Ethics of the World Medical Association (1964 Declaration of
Helsinki and later amendments) The study was approved by the Ethics
Committee at the Medical Faculty of the TU Dresden (Ethics Approval
No. EK 78032012) The study design was presented to the volunteers
in written form and written informed consent was obtained from each
individual participant.
Informed consent Written informed consent was obtained from each
individual participant.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article’s Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
1. Nordin S, Brämerson A (2008) Complaints of olfactory disor-
ders: epidemiology, assessment and clinical implications. Curr
Opin Allergy Clin Immunol 8(1):10–15
2. Croy I, Nordin S, Hummel T (2014) Olfactory disorders and
quality of life–an updated review. Chem Senses 39(3):185–194
3. Damm M, Temmel A, Welge-Lüssen A etal (2004) Olfactory
dysfunctions Epidemiology and therapy in Germany, Austria
and Switzerland. HNO 52(2):112–20
4. Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chem-
osensory changes experienced by patients undergoing cancer
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1334 European Archives of Oto-Rhino-Laryngology (2022) 279:1329–1334
1 3
chemotherapy: a qualitative interview study. J Pain Symptom
Manage 34(4):403–412
5. Ogawa T, Rutka J (1999) Olfactory dysfunction in head injured
workers. Acta Otolaryngol Suppl 540:50–57
6. Landis BN, Konnerth CG, Hummel T (2004) A study on
the frequency of olfactory dysfunction. Laryngoscope
114(10):1764–1769
7. Brämerson A, Johansson L, Ek L, Nordin S, Bende M (2004)
Prevalence of olfactory dysfunction: the skövde population-
based study. Laryngoscope 114(4):733–737
8. Fokkens WJ, Lund VJ, Mullol J etal (2012) European Position
Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl
23:3
9. Fokkens W, Desrosiers M (2019) Harvey R EPOS2020: develop-
ment strategy and goals for the latest European Position Paper on
Rhinosinusitis. Rhinology 57(3):162–168
10. Damm M, Schmitl L, Müller CA, Welge-Lüssen A, Hummel T
(2019) Diagnostics and treatment of olfactory dysfunction. HNO
67(4):274–281
11. Hummel T, Rissom K, Reden J, Hähner A, Weidenbecher M, Hüt-
tenbrink KB (2009) Effects of olfactory training in patients with
olfactory loss. Laryngoscope 119(3):496–499
12. Haehner A, Tosch C, Wolz M etal (2013) Olfactory training in
patients with Parkinson’s disease. PLoS One 8(4):e61680
13. Geißler K, Reimann H, Gudziol H, Bitter T, Guntinas-Lichius
O (2014) Olfactory training for patients with olfactory loss after
upper respiratory tract infections. Eur Arch Otorhinolaryngol
271(6):1557–1562
14. Altundag A, Cayonu M, Kayabasoglu G etal (2015) Modified
olfactory training in patients with postinfectious olfactory loss.
Laryngoscope 125(8):1763–1766
15. Damm M, Pikart LK, Reimann H etal (2014) Olfactory training is
helpful in postinfectious olfactory loss: a randomized, controlled,
multicenter study. Laryngoscope 124(4):826–831
16. Hummel T, Whitcroft KL, Andrews P etal (2017) Position paper
on olfactory dysfunction. Rhinology, Suppl 25(2017):1–30
17. Daramola OO, Becker SS (2015) An algorithmic approach to the
evaluation and treatment of olfactory disorders. Curr Opin Oto-
laryngol Head Neck Surg 23(1):8–14
18. Hummel T, Hüttenbrink KB (2005) Olfactory dysfunction due
to nasal sinus disease Causes, consequences, epidemiology, and
therapy. HNO 53(Suppl 1):S26-32
19. Brann DH, Tsukahara T, Weinreb C etal (2020) Non-neuronal
expression of SARS-CoV-2 entry genes in the olfactory system
suggests mechanisms underlying COVID-19-associated anosmia.
Sci Adv. https:// doi. org/ 10. 1126/ sciadv. abc58 01
20. Tian J, Pinto JM, Cui X etal (2016) Sendai Virus Induces Per-
sistent Olfactory Dysfunction in a Murine Model of PVOD via
Effects on Apoptosis, Cell Proliferation, and Response to ants.
PLoS One 11(7):e0159033
21. Hong SC, Holbrook EH, Leopold DA, Hummel T (2012) Dis-
torted olfactory perception: a systematic review. Acta Otolaryngol
132(Suppl 1):S27-31
22. Hummel T, Whitcroft KL, Rueter G, Haehner A (2017) Intranasal
vitamin A is beneficial in post-infectious olfactory loss. Eur Arch
Otorhinolaryngol 274(7):2819–2825
23. Hummel T, Heilmann S, Hüttenbrink KB (2002) Lipoic acid in
the treatment of smell dysfunction following viral infection of the
upper respiratory tract. Laryngoscope 112(11):2076–2080
24. Tanaka O, Mukaino Y (1999) The effect of auricular acupuncture
on olfactory acuity. Am J Chin Med 27:19–24
25. Hesse HP (2007) Akupunktur. In: Likar R, Wendtner F, Wenzel
G, Ausserwinkler M, Sittl R (eds) Bernatzky G. Nichtmedika-
mentöse Schmerztherapie – Komplementäre Nethoden in der
Praxis. Springer Verlag, Wien, p S 385-390
26. Stux G, Stiller N, Pothmann R, Jayasuriya A (1985) Akupunk-
tur—Lehrbuch und Atlas 2 Auflage. Springer Verlag, Berlin-
Heidelberg, p S 10–16-S 29–33
27. Stux G (2007) Akupunktur—Einführung, 7th edn. Springer-Ver-
lag, Berlin, p S.9–36-S.57–186
28. Stux G, Stiller N, Berman B, Pomeranz B (2008) Akupunktur –
Lehrbuch und Atlas, 7th edn. Springer Verlag, Berlin
29. Stör W, Irnich D (2009) Acupuncture: basics, practice, and evi-
dence. Schmerz 23(4):405–418
30. Vent J, Wang DW, Damm M (2010) Effects of traditional Chinese
acupuncture in post-viral olfactory dysfunction. Otolaryngol Head
Neck Surg 142(4):505–509
31. Silas J, Doty RL (2010) No evidence for specific benefit of acu-
puncture over vitamin B complex in treating persons with olfac-
tory dysfunction. Otolaryngol Head Neck Surg 143(4):603
32. Dai Q, Pang Z, Yu H (2016) Recovery of Olfactory Function in
Postviral Olfactory Dysfunction Patients after Acupuncture Treat-
ment. Evid Based Complement Alternat Med. https:// doi. org/ 10.
1155/ 2016/ 49860 34
33. Hauswald B, Tänzer K, Hüttenbrink KB (1998) Die Ergeb-
nisse der Akupunktur bei Patienten mit Hyp-bzw Anosmien.
In: Hauswald B, Tänzer K, Hüttenbrink KB (eds) Allergische
Erkrankungen von Haut und Schleimhäuten—Akupunktur im
Dialog. Hippokrates-Verlag, Stuttgart, p S 67-71
34. Anzinger A, Alberecht J, Kopietz R etal (2009) Effects of lasern-
eedle acupuncture on olfactory sensitivity of healthy human
subjects: a placebo-controlled, double-blinded, randomized trial.
Rhinology 47:153–159
35. Lin PS, Luo SD, Huang OY (2019) The application of bo’s
abdominal acupuncture on post-viral olfactory disorder after
steroid treatment failure: a case study. J Chin Med 30(2):119–129
36. Welge-Luessen A, Leopold DA, Miwa T (2013) Smell and Taste
Disorders - Diagnostic and Clinical Work-Up. In: Welge-Luessen
A, Hummel T (eds) Management of Smell and Taste Disorders - A
Practical Guide for Clinicians. Thieme, Stuttgart, pp 49–57
37. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) “Snif-
fin” sticks’: olfactory performance assessed by the combined
testing of odor identification, odor discrimination and olfactory
threshold. Chem Senses 22:39–52
38. Brinkhaus B, Witt CM, Ortiz M etal (2010) Acupuncture in sea-
sonal allergic rhinitis (ACUSAR)–design and protocol of a ran-
domised controlled multi-centre trial. Forsch Komplementmed
17(2):95–102
39. Gudziol V, Lötsch J, Hähner A, Zahnert T, Hummel T (2006)
Clinical significance of results from olfactory testing. Laryngo-
scope 116(10):1858–1863
40. Reden J, Mueller A, Mueller C, Konstantinidis I, Frasnelli J, Lan-
dis BN, Hummel T (2006) Recovery of olfactory function follow-
ing closed head injury or infections of the upper respiratory tract.
Arch Otolaryngol Head Neck Surg 132(3):265–269
41. Hedner M, Larsson M, Arnold N etal (2010) Cognitive factors in
odour detection, odour discrimination, and odour identification
tasks. J Clin Exp Neuropsychol 32(10):1062–1067
42. Liu F, Li ZM, Jiang YJ, Chen LD (2014) A meta-analysis of acu-
puncture use in the treatment of cognitive impairment after stroke.
J Altern Complement Med 20(7):535–44
43. Zhou L, Zhang YL, Cao HJ, Hu H (2013) Treating vascular
mild cognitive impairment by acupuncture: a systematic review
of randomized trials. Zhongguo Zhong Xi Yi Jie He Za Zhi
33(12):1626–30
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
1.
2.
3.
4.
5.
6.
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
accessing, sharing, receiving or otherwise using the Springer Nature journal content you agree to these terms of use (“Terms”). For these
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
apply.
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
detailed in the Privacy Policy.
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
not:
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
control;
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
otherwise unlawful;
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
writing;
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
content.
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
These terms of use are reviewed regularly and may be amended at any time. Springer Nature is not obligated to publish any information or
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at
onlineservice@springernature.com
... We identified 4469 records and included nine studies [21][22][23][24][25][26][27][28][29] with 687 patients, including six RCTs, two non-RCTs, and one retrospective co-hort study ( Table 1 ). The specific screening process is shown in Fig. 1 . ...
... No followup, registration, sample size estimation and virus types were reported. The TCM therapies in nine studies [21][22][23][24][25][26][27][28][29] were acupuncture, acupoint injection, and the non-TCM therapies were western medicine, olfactory training, and supplements. The main western medicine used were Prednisone acetate tablets, mometasone furoate nasal spray. ...
... Eight studies reported the symptom remission rate. [21][22][23][24][25][26][27][28] In symptom remission rate, acupuncture alone or acupoint injection was better than no treatment in one RCT 22 Acupuncture alone compared with western medicine (mometasone furoate nasal spray) showed beneficial results in one RCT, 28 and one RCT also showed better results for acupoint injection added on western medicine (prednisone acetate) and supplements (mecobalamin + ginkgo biloba extract) . 24 Two trials showed borderline statistical significance (one non-RCT 25 compared acupuncture with no treatment, one cohort study 27 compared acupuncture with oral vitamin B complex). ...
Article
Full-text available
Background Post-viral olfactory dysfunction (PVOD) is the common symptoms of long COVID, lacking of effective treatments. Traditional Chinese medicine (TCM) is claimed to be effective in treating olfactory dysfunction, but the evidence has not yet been critically appraised. We conducted a systematic review to evaluate the effectiveness and safety of TCM for PVOD. Methods We searched eight databases to identified clinical controlled studies about TCM for PVOD. The Cochrane risk of bias tools and GRADE were used to evaluate the quality of evidence. Risk ratio (RR), mean differences (MD), and 95 % confidence interval (CI), were used for effect estimation and RevMan 5.4.1 was used for data analysis. Results Six randomized controlled trials (RCTs) (545 participants), two non-randomized controlled trials (non-RCTs) (112 participants), and one retrospective cohort study (30 participants) were included. The overall quality of included studies was low. Acupuncture (n = 8) and acupoint injection (n = 3) were the mainly used TCM therapies. Five RCTs showed a better effect in TCM group. Four trials used acupuncture, and three trials used acupoint injection. The results of two non-RCTs and one cohort study were not statistically significant. Two trials reported mild to moderate adverse events (pain and brief syncope caused by acupuncture or acupoint injection). Conclusions Limited evidence focus on acupuncture and acupoint injection for PVOD and suggests that acupuncture and acupoint injection may be effective in improving PVOD. More well-designed trials should focus on acupuncture to confirm the benefit. Protocol registration The protocol of this review was registered at PROSPERO: CRD42022366776.
... More recently, Drews et al randomized 60 patients with PVOD of any duration to receive 12 sessions of verum or sham acupuncture. 21 A clinically significant improvement in olfaction defined as TDI score increase greater than 5.5 points was seen in 20% of the verum group compared to 10% of the sham group, although this did not reach statistical significance. Strictly defining the minimal clinically important difference in UPSIT and TDI scores would help estimate the effect size in subsequent randomized controlled trials investigating acupuncture as a treatment for PVOD. ...
Article
Full-text available
Background Olfactory dysfunction (OD) is a common symptom in patients with coronavirus disease 2019 (COVID-19) with limited treatment options. Objective This pilot study aimed to investigate an acupuncture protocol in patients with COVID-19 related OD. Methods Thirty patients were randomized into 2 groups. The standard group was treated with budesonide nasal irrigation and olfactory training. The acupuncture group received ten sessions of acupuncture therapy in addition to the standard group treatment. Olfaction was assessed using the University of Pennsylvania Smell Identification Test, 10-point visual analog scale, and Sino-Nasal Outcome Test at baseline and after 3 months of treatment. Differences between study arms were compared using Fisher’s exact and Wilcoxon rank sum tests. Results Eighteen of the 30 (60%) enrolled patients completed the study, including 11 (73%) in the standard and 7 (47%) in the acupuncture group. Reasons for participant drop-out included cost of travel and time constraints. There were no acupuncture complications. Conclusions Acupuncture as an adjunct therapy for COVID-19 related OD is well tolerated. Subsequent studies with larger sample sizes are needed to assess the effect of acupuncture on OD.
... (2022)[32] andLiu et al. (2020) [33].Patients visited the respective clinics at least twice with either 8 weeks (= 8w; recruitment period August 2012 to February 2013; Drews et al.) or 36 weeks (= 36w; recruitment period from 2008 to 2018; Liu et al.) between both consultations. The description of the study group is provided in the above mentioned publications. ...
Article
Full-text available
Background: Olfactory training (OT) is commonly used for the treatment of olfactory disorders. Nevertheless, there is an ongoing debate about the most effective OT regimen. We aimed to compare the effects of OT with 7 items (rose, lemon, eucalyptus, cloves, stewed apple, balm, mint) to 4-item-OT (rose, lemon, eucalyptus, cloves) over 3 months. Methods: Participants were 40 patients with olfactory dysfunction receiving 4-item-OT or 7-item-OT and 60 gender- and age-matched individuals with normal sense of smell receiving no OT, 4-item-OT, or 7-item-OT. Before and after the OT we assessed n-butanol odor thresholds, discrimination, and identification (TDI score), additionalthresholds for (R)-(-)-carvone, β-damascenone, salicyclic acid benzylester, the degree of phantosmia and parosmia, cognitive function, and ratings of olfactory function. Results: In both patient groups, the TDI score increased with the use of OT, regardless of the number of odors used (p < 0.001; 3.48 ± 4.21 and lower than control groups). The clinically significant increase of 5.5 points in TDI score correlated with change of ratings of parosmia (r 0.62; p < 0.01) and with ratings of olfactory dysfunction (r = 0.51; p < 0.05). Conclusion: Concluding, OT over a 3-months period with 4 or 7 odors appears to produce similar results, although the sample size has to be considered.
... In addition to the above, numerous other treatments have been tried, including but not limited to, palmitoylethanolamide and luteolin (660) , acupuncture (661) , lavender syrup (662) , famotidine (663) blockage of the stellate ganglion (664) , a mix of herbal drug (Tokishakuyaku-san) (665,666) , B vitamins (667) . They will not be described here in detail, because they await further study. ...
Article
Full-text available
Background: Since publication of the original Position Paper on Olfactory Dysfunction in 2017 (PPOD-17), the personal and societal burden of olfactory disorders has come sharply into focus through the lens of the COVID-19 pandemic. Clinicians, scientists and the public are now more aware of the importance of olfaction, and the impact of its dysfunction on quality of life, nutrition, social relationships and mental health. Accordingly, new basic, translational and clinical research has resulted in significant progress since the PPOD-17. In this updated document, we present and discuss currently available evidence for the diagnosis and management of olfactory dysfunction. Major updates to the current version include, amongst others: new recommendations on olfactory related terminology; new imaging recommendations; new sections on qualitative OD and COVID-19 OD; updated management section. Recommendations were agreed by all co-authors using a modified Delphi process. Conclusions: We have provided an overview of current evidence and expert-agreed recommendations for the definition, investigation, and management of OD. As for our original Position Paper, we hope that this updated document will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency, and generalisability of work in this field.
... In addition to the above, numerous other treatments have been tried, including but not limited to, palmitoylethanolamide and luteolin (660) , acupuncture (661) , lavender syrup (662) , famotidine (663) blockage of the stellate ganglion (664) , a mix of herbal drug (Tokishakuyaku-san) (665,666) , B vitamins (667) . They will not be described here in detail, because they await further study. ...
Article
Background: Since publication of the original Position Paper on Olfactory Dysfunction in 2017 (PPOD-17), the personal and societal burden of olfactory disorders has come sharply into focus through the lens of the COVID-19 pandemic. Clinicians, scientists and the public are now more aware of the importance of olfaction, and the impact of its dysfunction on quality of life, nutrition, social relationships and mental health. Accordingly, new basic, translational and clinical research has resulted in significant progress since the PPOD-17. In this updated document, we present and discuss currently available evidence for the diagnosis and management of olfactory dysfunction. Major updates to the current version include, amongst others: new recommendations on olfactory related terminology; new imaging recommendations; new sections on qualitative OD and COVID-19 OD; updated management section. Recommendations were agreed by all co-authors using a modified Delphi process. Conclusions: We have provided an overview of current evidence and expert-agreed recommendations for the definition, investigation, and management of OD. As for our original Position Paper, we hope that this updated document will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency, and generalisability of work in this field.
... It is believed that acupuncture may provide a resolution for OD. Some of the published papers have reported that acupuncture can induce significant improvement in smell function in patients with OD. 9, 10 We, therefore, propose performing a patient-blind, randomized controlled, cross-over study to evaluate whether acupuncture may be beneficial to post-COVID-19 patients who have a moderate or severe grade of OD. ...
Article
Objective Olfactory dysfunction (OD) is a common symptom of Corona Virus Disease 2019 (COVID-19). It is defined as the reduced or distorted ability to smell during sniffing (orthonasal olfaction) and represents one of the early symptoms in the clinical course of COVID-19 infection. A large online questionnaire-based survey has shown that some post-COVID-19 patients had no improvement 1 month after discharge from the hospital. Therefore, this clinical trial was designed to explore the efficacy of acupuncture for OD in COVID-19 infected patients and to determine whether acupuncture could have benefits over sham acupuncture for OD in post-COVID-19 patients. Methods This is a single-blind, randomized controlled, cross-over trial. We plan to recruit 40 post-COVID-19 patients with smell loss or smell distortions lasting for more than 1 month. Qualified patients will be randomly allocated to the intervention group (real acupuncture) or the control group (sham acupuncture) at a 1:1 ratio. Each patient will receive 8 sessions of treatment over 4 weeks (Cycle 1) and a 2-week follow-up. After the follow-up, the control group will be subjected to real acupuncture for another 4 weeks (Cycle 2), and the real acupuncture group will undergo the 4-week sham acupuncture. The primary outcomes will be the score changes on the questionnaire of olfactory functioning and olfaction-related quality of life at week 6, 8, 12, and 14 from the baseline. The secondary outcomes will be the changes in the olfactory test score at week 6 and 12 from the baseline measured by using the Traditional Chinese version of the University of Pennsylvania Smell Identification Test (UPSIT-TC). Discussion The results of this trial will help to determine the effectiveness of acupuncture for OD in post-COVID-19 patients. This may provide a new treatment option for patients.
Objective: This article seeks to systematically review existing literature on the use of acupuncture in treating olfactory dysfunction in order to better understand the methodology and efficacy of this alternative treatment modality. Methods: A comprehensive search of PubMed, Cochrane Library, Embase, Web of Science, and Google Scholar was conducted. The review was conducted by 2 independent reviewers that authored this article. Inclusion criteria included all studies analyzing the efficacy of acupuncture for treatment of olfactory dysfunction. Articles were excluded if they were duplicates, opinion or review papers, incomplete or unavailable papers, or if they were in a language other than English. Results: The review found 10 articles matching the inclusion criteria that overall showed a positive improvement in olfactory dysfunction after acupuncture intervention in multiple settings. Challenges highlighted in this review include variability in acupuncture protocols, such as differences in point selection, session frequency, and overall treatment duration, as well as the lack of standardized outcome measures for assessing olfactory function. Conclusion: This systematic review suggests acupuncture may have therapeutic effect on improvement of olfactory function across various types of olfactory disorders, most notably seen in post-viral anosmia. Given the variability in acupuncture protocols and lack of standardized outcome measures, there is a need for further research with standardized methods and larger sample sizes. Olfactory dysfunction is fundamentally a quality-of-life issue; advancing research could solidify acupuncture as a valuable and cost-effective addition to treatment plans, optimizing patient well-being.
Article
Objective] Herein, we report a case of a remarkably effective combination of acupuncture and daily olfactory training for treating postinfectious olfactory dysfunction that had not improved for years.[Case] A 45-year-old woman complained of decreased sense of smell and inability to smell properly. She had postinfectious olfactory dysfunction four years ago, which resulted in olfactory deglutition. She continued taking zinc preparations prescribed by the hospital; however, they showed no therapeutic response. She discontinued a yearlong hospital visit and received approximately 10 acupuncture sessions. Her odor problems gradually recovered to some extent after the acupuncture treatment, but dysphoria appeared. Her symptoms showed no significant changes over the next 3 years.[Results] The pretreatment olfactory VAS score was 38mm and the self-administered odor questionnaire score was 30%. Acupuncture treatment was focused on the facial area; thus, she was instructed to perform daily olfactory training by smelling various odors. Consequently, the olfactory VAS score improved to 97mm and the self-administered odor questionnaire score improved to 97.5% after 18 acupuncture sessions for 18 months.[Conclusion] The results indicated that the combination of acupuncture and daily olfactory training could improve postinfectious olfactory dysfunction that had not improved over the years.
Article
"Long COVID" is a sustained symptom following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to recent statistics, at least 65 million people have long COVID, which poses a long-term threat to human health. The pathogenic mechanisms of coronavirus disease 2019 (COVID-19) are complex and affect multiple organs and systems. Common symptoms include palpitations, breathing difficulties, attention and memory deficits, fatigue, anxiety, and depression. It is difficult to achieve satisfactory treatment effect with a single intervention. Currently, treatment strategies for long COVID are still in the exploratory stage, and there is an urgent need to find appropriate and effective methods for long COVID treatment. Traditional Chinese medicine is effective in treating the various phases of COVID-19. Previous studies have shown that acupoint stimulation therapy is effective in improving palpitations, dyspnea, cognitive impairment, anxiety, depression, and other symptoms in patients. According to previous studies, acupoint stimulation may improve various symptoms related to long COVID. This paper discusses the potential application value of acupoint stimulation in the treatment of long COVID-related symptoms, based on the common sequelae of various systems involved in long COVID, and the effect of acupoint stimulation in the treatment of similar symptoms and diseases in recent years.
Article
Full-text available
Altered olfactory function is a common symptom of COVID-19, but its etiology is unknown. A key question is whether SARS-CoV-2 (CoV-2) – the causal agent in COVID-19 – affects olfaction directly, by infecting olfactory sensory neurons or their targets in the olfactory bulb, or indirectly, through perturbation of supporting cells. Here we identify cell types in the olfactory epithelium and olfactory bulb that express SARS-CoV-2 cell entry molecules. Bulk sequencing demonstrated that mouse, non-human primate and human olfactory mucosa expresses two key genes involved in CoV-2 entry, ACE2 and TMPRSS2. However, single cell sequencing revealed that ACE2 is expressed in support cells, stem cells, and perivascular cells, rather than in neurons. Immunostaining confirmed these results and revealed pervasive expression of ACE2 protein in dorsally-located olfactory epithelial sustentacular cells and olfactory bulb pericytes in the mouse. These findings suggest that CoV-2 infection of non-neuronal cell types leads to anosmia and related disturbances in odor perception in COVID-19 patients.
Article
Full-text available
Background: Olfactory dysfunction is an increasingly recognised condition, associated with reduced quality of life and major health outcomes such as neurodegeneration and death. However, translational research in this field is limited by heterogeneity in methodological approach, including definitions of impairment, improvement and appropriate assessment techniques. Accordingly, effective treatments for smell loss are limited. In an effort to encourage high quality and comparable work in this field, among others, we propose the following ideas and recommendations. Whilst the full set of recommendations are outlined in the main document, points include the following: • Patients with suspected olfactory loss should undergo a full examination of the head and neck, including rigid nasal endoscopy with small diameter endoscopes. • Subjective olfactory assessment should not be undertaken in isolation, given its poor reliability. • Psychophysical assessment tools used in clinical and research settings should include reliable and validated tests of odour threshold, and/or one of odour identification or discrimination. • Comprehensive chemosensory assessment should include gustatory screening. • Smell training can be helpful in patients with olfactory loss of several aetiologies. Conclusions: We hope the current manuscript will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency and generalisability of work in this field.
Article
Full-text available
Background: Olfactory dysfunction is an increasingly recognised condition, associated with reduced quality of life and major health outcomes such as neurodegeneration and death. However, translational research in this field is limited by heterogeneity in methodological approach, including definitions of impairment, improvement and appropriate assessment techniques. Accordingly, effective treatments for smell loss are limited. In an effort to encourage high quality and comparable work in this field, among others, we propose the following ideas and recommendations. Whilst the full set of recommendations are outlined in the main document, points include the following: - Patients with suspected olfactory loss should undergo a full examination of the head and neck, including rigid nasal endoscopy with small diameter endoscopes. - Subjective olfactory assessment should not be undertaken in isolation, given its poor reliability. - Psychophysical assessment tools used in clinical and research settings should include reliable and validated tests of odour threshold, and/or one of odour identification or discrimination. - Comprehensive chemosensory assessment should include gustatory screening. - Smell training can be helpful in patients with olfactory loss of several aetiologies. Conclusions: We hope the current manuscript will encourage clinicians and researchers to adopt a common language, and in so doing, increase the methodological quality, consistency and generalisability of work in this field.
Article
Full-text available
Vitamin A plays a decisive role in the regeneration of olfactory receptor neurons. In this retrospective study we investigated the effectiveness of topical vitamin A in patients with post-infectious and posttraumatic smell disorders. Retrospective cohort. A total of 170 patients (age range 18–70 years, mean age 52 years) participated. Forty-six patients were treated with smell training only. The remaining 124 patients received smell training and topical vitamin A. Olfactory function was assessed using the Sniffin’ Sticks test kit, a validated technique to measure odor thresholds, discrimination and identification. The duration of olfactory training was 12 weeks. In patients receiving vitamin A, this was applied topically (head back position) at a dose of 10,000 IU/day for 8 weeks. Follow-up testing was performed approximately 10 months after the first assessment. Thirty-seven per cent of all post-infectious patients treated with vitamin A exhibited clinical improvement, whereas only 23% improved in controls. Using a Chi-square test, this was a significant result (χ² = 7.06, df = 2, p = 0.03). In addition, when comparing change in score after treatment, olfactory training + vitamin A produced significantly greater improvement compared with training alone, in discrimination score for all patients (1.4 points, p = 0.008), and in threshold and discrimination in the post-infectious group (1.6 points, p = 0.01 and 1.4 points, p = 0.04, respectively). Intranasal vitamin A at a dose of 10,000 IU per day for 2 months may be useful in the treatment of post-infectious olfactory loss. Further work with prospective, placebo-controlled studies is required to confirm these findings.
Article
Full-text available
To investigate the therapeutic effect of combined Xiao-Chaihu-Decoction and naturopathic medicine therapy on survival outcomes of patients’ PLC. In XCHD group ( n=76 ), patients were treated with Xiao-Chaihu-Decoction in accordance with the addition and subtraction theory of TCM; in NM group ( n=89 ), patients were managed by naturopathic medicine; in combined group ( n=70 ), the same volume of Xiao-Chaihu-Decoction combined with naturopathic medicine procedures was applied. There were no evident statistical differences of age, gender, KPS score, body weight, smoking status, AFP levels, HbsAg status, TBIL levels, tumor diameters, and numbers among different groups, showing comparability among groups. No significant difference was found regarding the total remission rate and stability rate of tumors in patients treated by Xiao-Chaihu-Decoction and naturopathic medicine, except the combined therapy. KPS scores were significantly improved after treatment among groups. After treatment, 52.8% cases maintained a stable or slight increase in weight, of which 42.1%, 48.3%, and 70.0% cases maintained weight stably in the XCHD group, NM group, and combined treatment group, respectively. Xiao-Chaihu-Decoction associated with naturopathy may predict improved prognostic outcomes in PLC patients, along with improved remission and stability rates, increased KPS scores, and stable weight maintenance.
Article
Full-text available
Background: Viral infection is a common cause of olfactory dysfunction. The complexities of studying post-viral olfactory loss in humans have impaired further progress in understanding the underlying mechanism. Recently, evidence from clinical studies has implicated Parainfluenza virus 3 as a causal agent. An animal model of post viral olfactory disorders (PVOD) would allow better understanding of disease pathogenesis and represent a major advance in the field. Objective: To develop a mouse model of PVOD by evaluating the effects of Sendai virus (SeV), the murine counterpart of Parainfluenza virus, on olfactory function and regenerative ability of the olfactory epithelium. Methods: C57BL/6 mice (6-8 months old) were inoculated intranasally with SeV or ultraviolet (UV)-inactivated virus (UV-SeV). On days 3, 10, 15, 30 and 60 post-infection, olfactory epithelium was harvested and analyzed by histopathology and immunohistochemical detection of S-phase nuclei. We also measured apoptosis by TUNEL assay and viral load by real-time PCR. The buried food test (BFT) was used to measure olfactory function of mice at day 60. In parallel, cultured murine olfactory sensory neurons (OSNs) infected with SeV or UV-SeV were tested for odorant-mixture response by measuring changes in intracellular calcium concentrations indicated by fura-4 AM assay. Results: Mice infected with SeV suffered from olfactory dysfunction, peaking on day 15, with no loss observed with UV-SeV. At 60 days, four out of 12 mice infected with SeV still had not recovered, with continued normal function in controls. Viral copies of SeV persisted in both the olfactory epithelium (OE) and the olfactory bulb (OB) for at least 60 days. At day 10 and after, both unit length labeling index (ULLI) of apoptosis and ULLI of proliferation in the SeV group was markedly less than the UV-SeV group. In primary cultured OSNs infected by SeV, the percentage of cells responding to mixed odors was markedly lower in the SeV group compared to UV-SeV (P = 0.007). Conclusion: We demonstrate that SeV impairs olfaction, persists in OE and OB tissue, reduces their regenerative ability, and impairs the normal physiological function of OSNs without gross cytopathology. This mouse model shares key features of human post-viral olfactory loss, supporting its future use in studies of PVOD. Further testing and development of this model should allow us to clarify the pathophysiology of PVOD.
Article
Background: The European Position Papers on Rhinosinusitis from 2005, 2007 and 2012 have had a measurable impact on the way this common condition with high impact on quality of life is managed around the world. EPOS2020 will be the latest iteration of the guideline, addressing new stakeholders and target users, presenting a summary of the latest literature and evolving treatment modalities, and formulating clear recommendations based on all available evidence. Methodology: Based on the AGREE II framework, this article demonstrates how the EPOS2020 steering group will address six key areas to ensure consistency in quality and presentation of information in the latest rhinosinusitis clinical practice guideline: scope and purpose; stakeholder involvement; rigour of development; clarity of presentation; recommendations and applicability; editorial independence. Results: By analysing the guidance from AGREE II, we formulated a detailed development strategy for EPOS2020. We identify new stakeholders and target users and ratify the importance of patient involvement in the latest EPOS guideline. New and expanded areas of research to be addressed are highlighted. We confirm our intention to use mixed methodologies, combining evidence-based medicine with real life studies; when no evidence can be found, use Delphi rounds to achieve clear, inclusive recommendations. We also introduce new concepts for dissemination of the guideline, using Internet and social media to improve accessibility. Conclusion: This article is an introduction to the EPOS2020 project, and presents the key goals, core stakeholders, planned methodology and dissemination strategies for the latest version of this influential guideline.
Article
Background Dysosmia is one of the most common disorders in otorhinolaryngology. However, epidemiological data are lacking and treatment strategies are insufficiently standardized. Objective The aim of this study was to evaluate the frequency of causes of olfactory disorders and the different therapeutic approaches used in ENT departments in German-speaking countries. The results were also compared to findings of the survey in 2000. Furthermore, a systematic review of treatment strategies was conducted. Materials and methods In 2010, a two-page survey addressing olfactory dysfunction was sent to all ENT departments in German-speaking countries. The literature review included sources such as PubMed, the Cochrane Library, and relevant guidelines. Results The diagnosis of dysosmia was made less frequently in ENT departments (decrease of 52%). The three most widely used therapeutic approaches were corticosteroids (topical and systemic) and systemic antibiotics. There is evidence in the literature showing a small to medium effect of topical steroids in sinonasal smell disorders. Conclusion Since a 50% decrease in the prevalence of olfactory disturbances is unlikely, the lower patient numbers may relate to a more critical diagnosis. The use of olfactory training in clinics has increased significantly (from <6% to up to 23%). The use of topical steroids for sinonasal dysosmia is evidence based. Smell training is a safe and effective treatment strategy, especially in post-infectious and post-traumatic olfactory disorders.
Book
Dieses Buch beweist, dass es möglich ist, westliche Medizin mit traditionellen chinesischen Konzepten zu verbinden: Einerseits wird das chinesische System von Meridianen und funktionellen Organen und die 120 wichtigsten Akupunkturpunkte gut verständlich beschrieben und ergänzt durch eine Einführung in Philosophie und Tradition der chinesischen Medizin. Andererseits wird die neurophysiologische Wirkung der Akupunktur auch aus moderner wissenschaftlicher Perspektive erklärt. Den Hauptteil des Buches macht die Therapie von Krankheiten aus, basierend auf westlichen Diagnosen. Für besonders häufig behandelte Krankheiten werden die jeweils wichtigsten Akupunkturpunkte erläutert – also wirklich das Buch eines Praktiker für die Praxis. Für die 7. Auflage aktualisiert: Der Stellenwert der Akupunktur in der derzeitigen gesundheitspolitischen Situation, neu definierte Qualitätsstandards für Ausbildung und Praxis, Ergebnisse der Modellstudien und weiterer aktueller klinischer Studien zur Wirksamkeit der Therapie.
Book
In 7. Auflage kompakter und in den Grundlagen-Kapiteln noch aktueller: "Der Stux" ist nach wie vor das fundierte und praxisbezogene Standardwerk mit wissenschaftlichen Informationen zu den Wirkmechanismen der Akupunktur. Es zeichnet sich durch seine erfahrungsbasierte Auswahl aus: wichtigste chinesische Diagnosen, Therapieprinzipien inklusive der jeweils relevanten Akupunkturpunkte für die einzelnen Störungsbilder. Klar, übersichtlich und zusätzlich illustriert: die wichtigsten Akupunkturpunkte, chinesische Konstitutionstypen und die wichtigsten chinesischen Syndrome im Überblick, alle bewährten Akupunkturindikationen sowie detaillierte Hinweise zur Durchführung der Therapie. Praktisch nützliches Wissen für Einsteiger und Profis.